Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets
Condition(s):Hyperuricemia; GoutLast Updated:January 23, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Hyperuricemia; GoutLast Updated:January 23, 2023Completed
Condition(s):Hyperuricemia; Gout; Chronic Kidney DiseasesLast Updated:June 23, 2023Terminated
Condition(s):Hyperuricemia; Gout; Chronic Kidney DiseasesLast Updated:June 22, 2023Completed
Condition(s):Hyperuricemia; GoutLast Updated:July 1, 2021Completed
Condition(s):HyperuricemiaLast Updated:July 23, 2021Completed
Condition(s):Enteric HyperoxaluriaLast Updated:June 10, 2022Terminated
Condition(s):Enteric HyperoxaluriaLast Updated:February 27, 2020Completed
Condition(s):Enteric Hyperoxaluria; Primary Hyperoxaluria; HyperoxalemiaLast Updated:December 30, 2020Completed
Condition(s):Secondary Hyperoxaluria; Nephrolithiasis; Hyperoxaluria; Kidney StonesLast Updated:October 28, 2021Completed
Condition(s):Secondary Hyperoxaluria; Nephrolithiasis; Hyperoxaluria; Kidney Stones; Dietary HyperoxaluriaLast Updated:January 19, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.